Skip to content

Exploratory study for dry eye patient satisfaction with treatment

Exploratory study for dry eye patient satisfaction with treatment - Exploratory study for dry eye patient satisfaction with treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030038
Enrollment
100
Registered
2017-11-20
Start date
2017-11-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

None listed

Sponsors

Santen Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 20 years of age or over Regardless of sex Diagnosed dry eye and use Diquafosol sodium ophthalmic solution or Sodium hyaluronate ophthalmic solution 0.1% for more than 3 months.

Exclusion criteria

Exclusion criteria: Having advanced ocular disorder due to ocular pemphigus or Stevens Johnson syndrome Using a punctal plug and performing a punctal closure procedure Diquafosol sodium ophthalmic solution and sodium hyaluronate ophthalmic solution are used in combination. Treated with Rebamipide suspension eye drop Subject with hypersensitivity to fluorescein The investigator judges that the subject is ineligible as the study subject.

Design outcomes

Primary

MeasureTime frame
Treatment satisfaction Factor analysis of satisfaction Relationship between patient background and ophthalmic findings / symptoms

Countries

Japan

Contacts

Public ContactKazuhisa Suwaki

Santen Pharmaceutical Co., Ltd. FOTE Team

clinical@santen.co.jp06-4802-9604

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026